Form 4 for CLGN CollPlant Biotechnologies Ltd

Accepted 2026-09-08 16:05:13 ET · period of report 2026-09-03 · accession 0001213900-26-098037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-09-08 16:05	2026-09-03	CLGN	Abelis Bar Berta	VP Legal	A - Grant	$0.00	+201.1K	206.4K	+3,795%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-09-03	A	A	201,141	$0.00	206,441	D	—	—	(F1) The Reporting Person was granted restricted share units ("RSUs"), each represents a contingent right to receive one ordinary share, no par value per share, of the Issuer ("Ordinary Shares"). The RSUs vest in accordance with the following vesting schedule: Thirty percent (30%) of the RSUs vest on September 3, 2027, and the remaining seventy percent (70%) vest in equal installments every three months thereafter over the following four years, such that the RSUs will be fully vested on September 3, 2031, subject to the Reporting Person's continued service to the Company through each vesting date. (F2) Effective as of September 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its Ordinary Shares (the 'Reverse Stock Split'). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. (F2) Effective as of September 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its Ordinary Shares (the 'Reverse Stock Split'). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. (F3) The total reported in Column 5 includes (i) 201,141 newly-awarded RSUs, (ii) 731 Ordinary Shares, and (iii) 4,569 previously-awarded RSUs.